类风湿关节炎患者人群队列中多病共存负担的综合评估
该研究基于明尼苏达州八县2015年1月1日 prevalent 类风湿关节炎(RA)患者及年龄、性别、县匹配的非RA对照,检索此前5年诊断代码,采用44种既定疾病和78个基于临床分类软件的非重叠慢性病类别评估多病共存负担;RA患者多病共存(≥2种疾病)占86% vs 非RA 71%(p<0.001),≥5种疾病占55% vs 38%(p<0.001),24/44种疾病及7/78个额外类别在RA中显著更常见。
要点
- RA患者多病共存(≥2种疾病)占86%,非RA对照占71%(p<0.001)。
- RA患者≥5种疾病占55%,非RA对照占38%(p<0.001)。
- 24/44种既定疾病及7/78个额外类别在RA中显著更常见。
核心结论
- RA患者较非RA受试者多病共存患病率更高,结果证实44种疾病列表并补充了若干RA中值得关注的疾病。
研究设计与样本
- 基于人群的研究,纳入2015年1月1日明尼苏达州八县现患RA居民及年龄、性别、县匹配的非RA对照,检索此前5年诊断代码。
- 采用相隔≥30天的两个诊断代码定义44种既定疾病和78个基于临床分类软件的非重叠慢性病类别。
- 共纳入1643例RA患者和1643例非RA受试者(女性72%,平均年龄63.1岁)。
主要发现
- RA患者中多病共存(≥2种疾病)1411例(86%)vs 非RA 1164例(71%)(p<0.001)。
- RA患者中≥5种疾病907例(55%)vs 非RA 619例(38%)(p<0.001)。
- 44种疾病中24种在RA中显著更常见,尤其是间质性肺病、纤维肌痛、骨关节炎和骨质疏松。
- 78个额外类别中7个在RA中显著更高,包括器质性睡眠障碍、维生素D缺乏和足部溃疡。
关键数值与推荐
- 多病共存定义为≥2种疾病,基于44种既定疾病列表。
- 采用错误发现率校正多重比较。
- 保留RA中更常见且患病率≥5%的疾病。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To comprehensively assess multimorbidity burden in patients with rheumatoid arthritis (RA) in order to unify the multimorbidity definition for RA research and clinical practice. METHODS: In this population-based study, residents of eight Minnesota counties with prevalent RA on 1 January 2015 were identified. Age, sex and county-matched non-RA comparators were selected from the same population. Diagnostic codes were retrieved for 5 years before 1 January 2015. Using two codes ≥30 days apart, 44 previously defined morbidities and 78 non-overlapping chronic disease categories based on Clinical Classification Software were defined. Prevalence of each morbidity in the RA versus non-RA cohorts was compared using false discovery rate to adjust for multiple comparisons. Morbidities more common in RA than non-RA and those with prevalence ≥5% were retained. RESULTS: 1643 patients with RA and 1643 non-RA subjects (72% women; mean age 63.1 years) were studied. Using the 44 morbidities, multimorbidity (defined as 2+ morbidities) was present in 1411 (86%) of RA and 1164 (71%) of non-RA subjects (p<0.001) with 5+ morbidities present in 907 (55%) of RA and 619 (38%) of non-RA (p<0.001). Patients with RA had significantly higher prevalence of 24 of the 44 morbidities compared with non-RA, especially interstitial lung disease, fibromyalgia, osteoarthritis and osteoporosis. Among the additional 78 categories, 7 were significantly higher in RA than non-RA, including organic sleep disorders, vitamin D deficiency and foot ulcers. CONCLUSION: Patients with RA have a higher prevalence of multimorbidity compared with non-RA subjects. These results confirm the list of 44 morbidities and add several other morbidities of interest in RA.
引用
- Crowson CS, Gunderson TM, Dykhoff HJ, et al. Comprehensive assessment of multimorbidity burden in a population-based cohort of patients with rheumatoid arthritis. RMD Open. 2022. PMID: 35042730. doi:10.1136/rmdopen-2021-002022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。